Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue — Trials · CancerIndex

Clinical trials

Registered studies

169 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04635683	Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma	withdrawn	Phase 1	0	Yazeed SawalhaOTHER	0	Sep 30, 2022	clinicaltrials
NCT02281279	Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma	withdrawn	Phase 1 / Phase 2	0	Mayo ClinicOTHER	0	Aug 11, 2016	clinicaltrials